APA (7th ed.) Citation

AM, W., C, P., P, S., JH, D., V, K., A, Y., . . . P, B. (2020). Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. Bone marrow transplantation, 55(8), 1540. https://doi.org/10.1038/s41409-020-0854-0

Chicago Style (17th ed.) Citation

AM, Willasch, et al. "Myeloablative Conditioning for Allo-HSCT in Pediatric ALL: FTBI or Chemotherapy?-A Multicenter EBMT-PDWP Study." Bone Marrow Transplantation 55, no. 8 (2020): 1540. https://doi.org/10.1038/s41409-020-0854-0.

MLA (9th ed.) Citation

AM, Willasch, et al. "Myeloablative Conditioning for Allo-HSCT in Pediatric ALL: FTBI or Chemotherapy?-A Multicenter EBMT-PDWP Study." Bone Marrow Transplantation, vol. 55, no. 8, 2020, p. 1540, https://doi.org/10.1038/s41409-020-0854-0.